autologous anti-CD22 CAR-T cells CLIC-2201
Term · Oncology and biomedicine · MLC-T-ONC-011396
A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD22, with potential antineoplastic activity. Upon administration, autologous anti-CD22 CAR-T cells CLIC-2201 recognize and kill CD22-expressing tumor cells. CD22, a B-lineage-restricted, transmembrane phosphoglycoprotein, is expressed on malignant B cells.
| Identifier | MLC-T-ONC-011396 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CLIC-2201; autologous anti-CD22 CAR T cells CLIC-2201; autologous CD22-targeting CAR T cells CLIC-2201 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011396",
"term": "autologous anti-CD22 CAR-T cells CLIC-2201",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD22, with potential antineoplastic activity. Upon administration, autologous anti-CD22 CAR-T cells CLIC-2201 recognize and kill CD22-expressing tumor cells. CD22, a B-lineage-restricted, transmembrane phosphoglycoprotein, is expressed on malignant B cells.",
"synonyms": [
"CLIC-2201",
"autologous anti-CD22 CAR T cells CLIC-2201",
"autologous CD22-targeting CAR T cells CLIC-2201"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-cd22-car-t-cells-clic-2201/"
}
Record 2,728 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.